Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Funding types
Funding types
Shareholder Investment
Products 41 to 50 of 129
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Detalzym GA L-E5 Glucoamylase
by
BASF
+
Verenium
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
Germany
+
USA
+
China
+
Japan
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/12/26 15:16 (6 years ago)
Known funding amount:
2,147,483,647 EUR
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
No longer on the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BAS
(ETR)
Value chain stage:
Input
digitalDNA
by
Applied DNA Sciences
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/01/30 12:02 (6 years ago)
Known funding amount:
19,800,000 USD
Funding types:
Shareholder Investment
Industry:
Security
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Forensic Tagging
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
APDN
(NASDAQ)
Value chain stage:
Platform
Dragon Silk
by
Kraig Biocraft Laboratories
Biotech components:
Animal
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
+
Vietnam
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
5,000,000 USD
Funding types:
Government
+
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Fiber
Production process:
Closed Production
Source:
Scientist Magazine
Trading symbol:
KBLB
(OTCMKTS)
Value chain stage:
Input
Encapso
by
Solazyme
+
Encapso
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
+
Middle East
+
Canada
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/04/01 16:30 (6 years ago)
Known funding amount:
174,900,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
SZYM
(NASDAQ)
Value chain stage:
Finished Product
Engineered Tilapia
by
Intrexon
Biotech components:
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:57 (5 years ago)
Date last modified:
2019/09/12 14:59 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Food
Production process:
N/A
Source:
N/A
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Eradicake Alpha-Amylase
by
BASF
+
Verenium
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
USA
+
Mexico
+
Canada
+
Germany
+
Singapore
+
Brazil
+
China
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/12/26 15:23 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BAS
(ETR)
Value chain stage:
Input
EveNootkatone
by
Evolva
Biotech components:
Plant
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
USA
+
Europe
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Additive
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Input
EverSweet™
by
Evolva
+
Cargill
Biotech components:
Plant
Business models:
B2B
+
B2C
Country of production:
Switzerland
Country of distribution:
USA
+
Europe
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/13 15:54 (6 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Chemical
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Input
Farnesene
by
Amyris
Biotech components:
Fungus
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
471,900,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
AMRS
(NASDAQ)
Value chain stage:
Input
fiberTyping
by
Applied DNA Sciences
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/01/30 11:57 (6 years ago)
Known funding amount:
19,800,000 USD
Funding types:
Shareholder Investment
Industry:
Security
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Forensic Tagging
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
APDN
(NASDAQ)
Value chain stage:
Finished Product
1
2
3
4
5
6
7
8
9
10
…
13
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
